Mr. Zhongyang Shang is Independent Director of Biostar Pharmaceuticals, Inc. He is also the chairman of the board of directors? compensation committee. Mr. Shang is currently the director of Shaanxi Province Administration of Industry and Commerce?s Bureau of Fair Trading, a position he has held since 2006. From 1996 to 2006, Mr. Shang was the director of the Administration of Industry and Commerce for the municipalities of Tongchuan and Xianyang in Shaanxi Province. Mr. Shang is a graduate of the Central Party College of Economics and Management.
Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating and Governance Committee
Age: 58 Chairman Since 2009
The company has return on total asset (ROA) of (11.72) % which means that it has lost $11.72 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (31.39) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 4.78 M in liabilities with Debt to Equity (D/E) ratio of 0.08 which may suggest the company is not taking enough advantage from borrowing. Biostar Pharmaceuticals Inc has Current Ratio of 3.62 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Entity SummaryBiostar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of overthecounter and prescription pharmaceutical solutions for various diseases and conditions in the People?s Republic of China. Biostar Pharmaceuticals Inc [BSPM] is traded on NASDAQ General Markets in USA. It is located in Biostar Pharmaceuticals, Inc.Xianyang City, and employs 439 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| BSPM Nasdaq
Biostar Pharmaceuticals Inc
Biostar Pharmaceuticals Inc has less than 47.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Biostar price boundaries
Promote Biostar and Zhongyang Shang